Read More Pharma Industry News Is co-administered COVID prophylaxis with antibodies and mRNA vaccines the next FDA-backed model? Invivyd’s LIBERTY trial explores co-administered COVID prevention with VYD2311 and mRNA vaccines. See how this could influence FDA and payer strategies. bySoujanya RaviFebruary 6, 2026